New Bill Would Require FDA to Allow Marketing of CBD in Dietary Supplements

Photo: Pexels

Originally Appeared in Presence Marketing News, February 2020
By Steven Hoffman

A bill introduced in the U.S. House of Representatives would allow  hemp-derived CBD to be marketed in dietary supplements and food products. Introduced by Collin Peterson (D-MN), Chair of the House Agriculture Committee, the bill would explicitly include hemp-derived CBD in the definition of a dietary supplement, reports New Hope Network. The bill is important, reports Marijuana Moment, because, while hemp and its derivatives were federally legalized under the 2018 Farm Bill, according to former FDA Commissioner Scott Gottlieb, it could take years for the FDA to finalize rules around allowing hemp-derived cannabidiol (CBD) in dietary supplements and food products—unless Congress steps in, he said. The legislation, filed on January 14, 2020, if passed would amend the Federal Food, Drug and Cosmetics Act to include CBD in the definition of dietary supplements. “The last two Farm Bills were landmark successes for hemp, but we are still very early in this process, and growers need regulatory certainty. This bill will allow FDA to regulate CBD that comes from hemp as a dietary supplement, providing a pathway forward for hemp-derived products. It would also identify barriers to success for hemp farmers, informing growers and policy makers of the challenges facing this new industry,” said Congressman Peterson in a statement. Learn more about current FDA, USDA, and state-level hemp and CBD policy and regulation at the upcoming 7th Annual NoCo Hemp Expo, the world’s largest exposition, conference and gathering of hemp industry professionals, March 26-28, 2020, at the National Western Complex in Denver, CO.